XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis
作者： Dimitrios Pectasides , George Papaxoinis , Konstantine T Kalogeras , Anastasia G Eleftheraki , Ioannis Xanthakis
关键词:
摘要: Background The aim was to compare two standard chemotherapy regimens combined with bevacizumab as first-line treatment in patients metastatic colorectal cancer.
biomedcentral.com
springer.com
doaj.org参考文章(26)
Wang Likui, Wang Hong, Zhang Shuwen, Clinical Significance of the Upregulated Osteopontin mRNA Expression in Human Colorectal Cancer Journal of Gastrointestinal Surgery. ,vol. 14, pp. 74- 81 ,(2010) , 10.1007/S11605-009-1035-Z
Suntaek Hong, Connection between inflammation and carcinogenesis in gastrointestinal tract: Focus on TGF-β signaling World Journal of Gastroenterology. ,vol. 16, pp. 2080- 2093 ,(2010) , 10.3748/WJG.V16.I17.2080
Kang Sup Shim, Kwang Ho Kim, Woon Sup Han, Eung Bum Park, Elevated serum levels of transforming growth factor-β1 in patients with colorectal carcinoma Cancer. ,vol. 85, pp. 554- 561 ,(1999) , 10.1002/(SICI)1097-0142(19990201)85:3<554::AID-CNCR6>3.0.CO;2-X
J.-C. Lee, N.-H. Chow, S.-T. Wang, S.-M. Huang, Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients European Journal of Cancer. ,vol. 36, pp. 748- 753 ,(2000) , 10.1016/S0959-8049(00)00003-4
H Robson, E Anderson, RD James, PF Schofield, Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients. British Journal of Cancer. ,vol. 74, pp. 753- 758 ,(1996) , 10.1038/BJC.1996.432
M Degirmenci, BETÜL Karaca, G Gorumlu, R Durusoy, G Demir Piskin, MT Bozkurt, YALÇIN Cirak, D Tunali, BÜLENT Karabulut, UA Sanli, R Uslu, None, Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer Medical Oncology. ,vol. 27, pp. 585- 591 ,(2010) , 10.1007/S12032-009-9253-5
Hakan Akbulut, Fevzi Altuntas, K Gonca Akbulut, Guler Ozturk, Mehmet Cindoruk, Ekrem Unal, Fikri Icli, None, Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma. Cytokine. ,vol. 20, pp. 184- 190 ,(2002) , 10.1006/CYTO.2002.1993
P Khosravi, M Martin, P García-Alfonso, A J Muñoz-Martin, S Alvarez-Suarez, Y Jerez-Gilarranz, M Riesco-Martinez, Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer. British Journal of Cancer. ,vol. 103, pp. 1524- 1528 ,(2010) , 10.1038/SJ.BJC.6605907
Akeila Bellahcène, Vincent Castronovo, Kalu U. E. Ogbureke, Larry W. Fisher, Neal S. Fedarko, Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer Nature Reviews Cancer. ,vol. 8, pp. 212- 226 ,(2008) , 10.1038/NRC2345
Ferdinando De Vita, Michele Orditura, Eva Lieto, Stefania Infusino, Floriana Morgillo, Erika Martinelli, Paolo Castellano, Ciro Romano, Fortunato Ciardiello, Giuseppe Catalano, Carlo Pignatelli, Gennaro Galizia, Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. Cancer. ,vol. 100, pp. 270- 278 ,(2004) , 10.1002/CNCR.11911